TY  - RPRT
        AU  - Daysal, N. Meltem
AU  - Fredrickson, Camille
AU  - Kristiansen, Ida Lykke
AU  - Trandafir, Mircea
AU  - Zhang, Jonathan
        TI  - The Labor Market Impacts of GLP-1s
        PY  - 2026/Jul/
        PB  - Institute of Labor Economics (IZA)
        CY  - Bonn
        T2  - IZA Discussion Paper
        IS  - 18787
        UR  - https://www.iza.org/publications/dp18787
        AB  - We estimate the causal impacts of GLP-1 treatment on labor market outcomes using linked Danish administrative data and a matched stacked difference-in-differences design. We compare patients who initiate GLP-1 treatment during the first two years of Semaglutide availability to observably similar patients who initiate four years later. We find that GLP-1 treatment reduces long-term sickness leave by 17.3%. We estimate total fiscal benefits of GLP-1 initiation of approximately 1.3–1.5% of annual labor income per employed individual. We do not detect statistically significant or economically meaningful impacts on income, labor force participation, or employment over four years.
        KW  - GLP-1
KW  - diabetes
KW  - obesity
KW  - fiscal spillover
        ER  -